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 22 
Abstract 23 
Objectives: To determine variation at the genome level in Escherichia coli ST131 clinical 24 
isolates previously shown to be phenotypically diverse. 25 
Methods: Ten ST131 isolates extensively characterised in previous studies were genome 26 
sequenced using combinations of Illumina and 454 sequencing technology. Whole genome 27 
comparisons and phylogenetic comparisons were then performed across the strain set and 28 
with other closely related ExPEC strain types 29 
Results: E. coli ST131 is over-represented in a collection of clinical isolates, and there is 30 
large phenotypic variation amongst isolates. Genome sequencing of a selection of non-related 31 
clinical isolates in contrast shows almost no genomic variation between ST131 strains, and E. 32 
coli ST131 shows evidence of a genetically monomorphic pathogen showing similar 33 
evolutionary trend to hypervirulent Clostridium difficile. 34 
Conclusions: A dominant circulating clone of E. coli ST131 has been identified in unrelated 35 
clinical urine samples in the UK. The clone splits into two distinct subgroups on the basis of 36 
antimicrobial resistance levels and carriage of ESBL plasmids. This provides the most 37 
comprehensive snapshot to date of the true molecular epidemiology of ST131 clinical isolates.  38 
 39 
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 40 
Introduction 41 
Urinary tract infections (UTI) are among the most common bacterial infectious diseases in 42 
the world, with an estimated 20% of women over the age of 18 suffering from a UTI in their 43 
lifetime 1. Of those infections among otherwise healthy women, some 80% are caused by 44 
Escherichia coli 1. All E. coli which cause UTI are classified on the basis that that they are a 45 
pathovar of the species which cause extra-intestinal disease, and are termed Extra-Intestinal 46 
pathogenic E. coli, or ExPEC. This classification works on the basis that a subset of E. coli 47 
exist which are capable of causing infectious disease at sites other than the intestine, and also 48 
incorporates avian pathogenic E. coli, septicaemia E. coli and new born meningitis E. coli 2. 49 
In addition to the disease burden of UTI, ExPEC are also of significant importance due to the 50 
levels of antimicrobial resistance observed in isolates. Epidemiological studies show 51 
resistance to front line antibiotics such as ciprofloxacin and trimethoprim in as many as 20% 52 
- 45% of isolates tested in large cohorts across Europe, North, and South America 1, 3. Of 53 
greater concern is the observed level of extended spectrum β-lactamase (ESBL) gene carriage 54 
in ExPEC 4, 5. ESBL render bacteria resistant to multiple antimicrobials including the 55 
cephalosporins, meaning that only carbapenems remain as a drug of choice for treatment of 56 
some ESBL producers. 57 
Molecular epidemiological analysis of ESBL positive ExPEC isolates by multi-locus 58 
sequence typing (MLST) has uncovered the emergence of an apparently dominant sequence 59 
type of ExPEC among UTI and other extra-intestinal infections, namely ST131. The 60 
sequence type is composed of E. coli O25b:H4 strains, and has been implicated as the major 61 
cause of dissemination of the CTX-M-15 class of ESBL gene 6. ST131 isolates are also 62 
unusual in that they counter the accepted dogma that bacteria exhibiting high levels of 63 
antimicrobial resistance do so at the expense of a fitness advantage which results in decreased 64 
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pathogenesis 1. ST131 strains reportedly exhibit increased pathogenesis 7 associated with high 65 
levels of virulence associated gene carriage (VAG) 8, and have been implicated in large scale 66 
disease outbreaks 9, 10, leading to the hypothesis that ST131 is a pandemic ExPEC clone 11.  67 
Previous work by our group investigated the organisms present in polymicrobial and 68 
monomicrobial urine samples, and uncovered the presence of E. coli exhibiting high levels of 69 
antimicrobial resistance and a hyper-invasive phenotype in in vitro cell culture experiments 3. 70 
Further characterisation of the isolates showed that ST131 was the dominant strain type 71 
within the collection, that the ST131 strains were responsible for the high levels of 72 
antimicrobial resistance observed in the collection, and that there was variation in VAG 73 
profile between strains, with no specific VAG profile associated with ST131 strains 12. To 74 
address the dichotomy between the observations from our previous studies and the suggestion 75 
that ST131 is a pandemic clone with specific traits, we investigated a group of ExPEC ST131 76 
strains isolated from the urinary tracts of elderly patients from a mixture of both Hospital and 77 
community settings. Mapping of phenotypes against sequence type showed wide variation in 78 
exhibited phenotypes within the ST131 cluster. An improved quality draft genome sequence 79 
for one isolate, and draft genome sequences for a further nine isolates, showed no variation in 80 
gene content between the isolates. SNP based phylogeny shows the strains are genetically 81 
homogenous and that the isolates sub-cluster according to antimicrobial resistance and ESBL 82 
plasmid carriage. In combination our data shows the circulation of a dominant ST131 clone 83 
among unrelated cases of urinary tract infection in the UK, and raises the question of ST131 84 
being a monomorphic pathogen who’s selection is being driven by antimicrobial resistance. 85 
 86 
Materials and methods: 87 
Strains 88 
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One hundred and fifty E. coli were isolated from 250 culture plates collected at random from 89 
Nottingham University Hospitals (NUH) between October 2008 and June 2009 as part of a 90 
larger study into UTI causative agents 3. E. coli ST131 strains and outlier ST12 strain 91 
selected for genome sequencing analysis are listed in table 1. Antibiotic susceptibility profiles, 92 
VAG carriage and in vitro invasion phenotypes were obtained as described previously 3, 12. 93 
 94 
Multi Locus Sequence Typing 95 
MLST was performed using the Achtman typing scheme (http://mlst.ucc.ie/mlst/dbs/Ecoli), 96 
adhering to the protocols published on the website. Bionumerics v.6.5 was used to generate a 97 
minimum spanning tree from non-concatenated sequences of the 7 alleles. 98 
 99 
Genome sequencing of ST131 strains 100 
For Illumina sequencing, genomic DNA was sheared into 300bp fragments, libraries prepared 101 
using the Illumina Tru-Seq Genomic library preparation kit and multiplexed using 6bp index 102 
sequences into a single lane. They were then sequenced using paired-end 72bp reads on an 103 
Illumina GAIIx platform using SCS 2.8 software. Samples were filtered using the FASTX 104 
toolkit (v 0.13) and remapped using Bowtie 0.12.7 to the UTI89 reference genome using a 105 
minimum insert length of zero and a maximum of 600. Other parameters were left as default.  106 
Suspected PCR duplicate SNPs were called using the SAMtools (0.18) utilities. A minimum 107 
depth of 8x was required before SNP calling at a given position could begin. De novo 108 
assemblies of the genome were performed using Velvet 1.0.18 and the VelvetOptimiser script 109 
(version 2.1.7). ORFs were called using a minimum size of 102 nt and blast and PFAM scans 110 
were run of the resulting ORFs. For 454 sequencing genomic DNA for each strain was 111 
sheared into approximately 8 kb fragments. Paired-end libraries were prepared, according to 112 
the Roche/454 Sequencing 8 kb Paired End Library Preparation Method Manual. Emulsion 113 
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PCRs were performed for enrichment titration and sequencing according to the manufacturer 114 
(Roche/454 Sequencing). Titanium sequencing for each library was performed on a 454 GS-115 
FLX apparatus. The reads were assembled and scaffolded using Newbler version 2.5.  116 
 117 
Comparative genomics 118 
Genome sequence annotation was manually curated using Artemis and Blast functions. 119 
Genomes were compared in a pairwise fashion using BRIG 13. To determine levels of SNP 120 
variation in the reference genomes for strains belonging to ST95 and ST73, genome 121 
sequences were aligned using progressiveMauve, and the SNP data exported to a spreadsheet. 122 
SNPs were manually curated to remove any ambiguous calls, and to remove insertions.  123 
 124 
 Whole genome based phylogeny reconstruction 125 
Phylogeny of ST131 in relation to the UTI89 reference genome and the outlier ST12 strain 126 
was performed by aligning genome sequences using progressiveMauve 14 and the common 127 
core genome extracted using the stripSubsetLCBs script. Bayesian phylogeny was inferred 128 
using ClonalFrame 15 from the 50% consensus of 10 runs with 10,000 iterations following a 129 
burn in phase of 10,000 iterations, with the quality of each run manually checked using 130 
Tracer. Phylogenetic trees were produced and edited using FigTree. 131 
 132 
Results: 133 
Phenotypic variation in E. coli ST131 isolated from unrelated clinical UTI cases. 134 
As part of a wider study into the microbial population of urinary tract infections in elderly 135 
patients, 150 E. coli were isolated from 250 unrelated clinical urinary tract samples belonging 136 
to patients aged 70 or over across the East Midlands area of the United Kingdom 3, which 137 
contains a population of around 5 million people. During this study variation in antimicrobial 138 
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resistance and epithelial cell invasion was demonstrated within the E. coli isolates 3. To 139 
assess the phenotypic variation that existed within the E. coli ST131 population, and compare 140 
against other ST types, epithelial cell invasion (Fig 1A) and antimicrobial resistance levels 141 
(Fig1B) were overlaid against a minimum spanning tree (MST) of the ExPEC isolates. The 142 
overlaid MST show variation in phenotypes within the ST131 isolates. There is variation in 143 
levels of antimicrobial resistance within the group and in the ability to exhibit the high cell 144 
invasion phenotype described previously in this group of isolates 3.    145 
 146 
Improved quality draft genome of an ST131 isolate uncovers common ExPEC genomic 147 
traits. 148 
In an attempt to further characterise E. coli ST131, one isolate from our strain collection was 149 
chosen for high quality draft genome sequencing. Strain UTI18 was chosen as it is highly 150 
antimicrobial resistant with average invasion levels (table 1), and was sequenced using a 151 
combination of Illumina and 454 sequencing. UTI18 is equivalent to the recently published 152 
NA114 E.. coli ST131 genome sequence 20 in that it contains no discernible “novel” regions 153 
which would account for increased fitness or pathogenicity when compared to the available 154 
genomes of ExPEC isolates (fig 2). The pathogenicity island (PAI) which encodes cnf, 155 
haemolysin and the intact pap operon has been deleted, as has the sfa fimbrial operon, and 156 
there is a transposase insertion in the fimB gene of the Type I fimbriae operon. UTI18 does 157 
contain a fully intact High Pathogenicity Island encoding the yersiniabactin locus, and also 158 
contains two flagella encoding regions. The first region is identical to the flagella operons 159 
present in other publicly available ExPEC genome sequences, whilst the second is a truncated 160 
version of Flag-2 found in the enteroaggregative E. coli O42 genome sequence 16, and in 161 
ExPEC strain UMN026, as well as the publicly available E. coli O111 and O26 EPEC 162 
genome sequences.  163 
Page 7 of 26
Journal of Antimicrobial Chemotherapy: under review
Journal of Antimicrobial Chemotherapy
Confidential: for peer review only
Comparative analysis of regions outside the accessory virulome of ExPEC highlighted 164 
differences in metabolic pathways encoding genes between ST131 and the other publicly 165 
available ExPEC genome sequences. The idnK and idnDOTR operons, encoding for the L-166 
idonate catabolism pathway are fully deleted in ST131. The pathway is a subsidiary pathway 167 
for Gluconate metabolism in E. coli and is also termed the GntII system 17. The ancestral asc 168 
operon encoding a combined arbutin/salicin/cellobiose uptake and metabolism pathway is 169 
also affected by deletions of ascF and ascB, the PTS transporter enzyme and phospho-beta-170 
glucosidase enzyme respectively which are transcribed from a single promoter 18. Also 171 
deleted are the putative ABC transporter genes yddA and yddB, and the yrhA and yrhB genes 172 
present in a region encoding for both the GntI gluconate uptake and metabolism pathway and 173 
the GGT small peptide transporter 19.  174 
Illumina sequencing of unrelated ST131 clinical isolates suggests circulation of a 175 
genetically homogeneous clone. 176 
In order to confirm that the high quality draft genome sequence strain was representative of 177 
our population, a further nine ST131 strains isolated from unrelated clinical samples and 178 
displaying varied phenotypic traits (table 1) were sequenced using the Illumina GAIIx (eight 179 
isolates) or 454 (one isolate), with draft de novo assemblies produced. Stepwise BLAST 180 
comparisons using BRIG 13 were performed of the draft de novo assembled genome 181 
sequences against our improved quality UTI18 genome sequence, and against the recently 182 
announced NA114 genome sequence of an Indian ST131 isolate 20. These comparisons 183 
showed no strain specific insertions or deletions of accessory mobile islands within our strain 184 
set, but 2 regions differing from NA114 which were annotated as fragments of plasmids (Fig 185 
3). This heterogeneity is not observed in ST73 and ST95, where there is variation in carriage 186 
of pathogenicity islands between strains within the complex.  187 
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SNP profiling of the strains which were Illumina sequenced was performed against the 188 
publicly available UTI89 reference genome sequence as well as the genome sequence of 189 
UTI48, an ST12 isolate from our strain collection. SNP profiling shows that the ST131 190 
strains are genetically homogeneous. There were a total of 15,060 SNPs conserved between 191 
the ST131 strains compared to UTI89, with 1,324 SNPS between the ST131 strains, 371 of 192 
which are non-synonymous. Strain UTI226 was the most divergent amongst our cohort but 193 
had only 460 strain-specific SNPs, with the remaining strains having only 10 – 60 strain 194 
specific SNPs. Such low level SNP variation is unreported in E. coli and rare in 195 
enterobacteriaceae in general, and is more akin to monomorphic highly pathogenic and host 196 
restricted subsets of species such as Salmonella Typhi 21. To ascertain if this monomorphic 197 
observation was common across E. coli ST complexes the level of SNP variation was 198 
determined in ST95 and ST73 using the publicly available genome sequences of strains from 199 
those complexes (Table 2). ProgressiveMauve alignments were performed, and the extracted 200 
SNP file manually curated to remove deletions and ambiguous SNP calls. The results showed 201 
14, 413 SNPs between the three ST95 strains, and 9, 059 SNPs between the two ST73 strains. 202 
Mapping of the ST131 specific SNPs against the UTI18 genome showed that the SNPs were 203 
not randomly distributed suggesting that recombination has played a significant role in the 204 
emergence of our ST131 clone (fig 4). The metabolic operons glc, glp, ytf, and tre are all 205 
ST131 SNP hotspots, as is the fim operon. Conversely both flagella operons and the HPI 206 
show no SNPs at all. 207 
Whole genome alignments were performed on our ten ST131 isolates, NA114, the ST12 208 
outlier strain UTI48, and the reference genome UTI19, and phylogeny reconstructed using 209 
Clonalframe 15.  When strain phenotypes were mapped against the resulting phylogenetic tree 210 
(Fig 5) there was a split between CTX-M-15 plasmid positive isolates and non CTX-M 211 
negative strains, which also mirrored levels of antimicrobial resistance observed in the 212 
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isolates. In addition the CTX-M positive strains also had identical VAG profiles using a 213 
multiplex PCR detection method 12. There was no correlation with invasive phenotype, 214 
community or hospital acquisition, or clinical recurrence of UTI in patients the original strain 215 
was isolated from.  216 
 217 
Discussion 218 
Extra-intestinal pathogenic E. coli, ExPEC, are an extremely diverse group of organisms 219 
classified according to disease pathology. A number of E. coli genotypes, as defined by 220 
Multi-locus sequence typing classification, are capable of causing extra-intestinal infection 22, 221 
and genome sequencing combined with comparative genomics of ExPEC isolates has shown 222 
no classical genetic blueprint for an E. coli to become a successful ExPEC strain 23-25. 223 
Recently E. coli ST131 has emerged as the most frequent ST isolated from human clinical 224 
cases of ExPEC infection, leading to it being tagged as an emerging pandemic E. coli 11, 26. In 225 
particular ST131 ExPEC have garnered interest for their role in the rapid spread of the CTX-226 
M15 Extended spectrum β-lactamase determinant, conferring multiple drug resistance to 227 
extra-intestinal infectious agents 9, 12, 27. This emergence of a dominant ExPEC strain type is 228 
in contrast to the hypothesis that there is no set genomic blueprint for a successful ExPEC 229 
strain.  230 
Previous work by our group showed variation in phenotypic characteristics among ExPEC 231 
isolated from elderly patients 3. Molecular epidemiology on this group of strains uncovered a 232 
large proportion of ST131 isolates within the population exhibiting variation in virulence 233 
associated gene carriage 12. In this study we further investigated this apparent variation in 234 
phenotypes of ST131 by mapping phenotypic traits against a minimum spanning tree of our 235 
ExPEC population. Our data corroborates the current ST131 literature reporting significant 236 
increases of isolation of the organism from extra-intestinal infections with ST131 the most 237 
Page 10 of 26
Journal of Antimicrobial Chemotherapy: under review
Journal of Antimicrobial Chemotherapy
Confidential: for peer review only
common ST isolated in our ExPEC population. Our data also shows variation in phenotypes 238 
observed within our ST131 population, correlating with our earlier observation of variation in 239 
virulence associated gene carriage within the cohort 12. Most reports of ST131 populations 240 
have focussed on the likelihood of an emerging clone, and focus on the ST131 isolates 241 
carrying CTX-M variants, however our previous work 12 combined with data presented here, 242 
show that clinical ST131 isolates are phenotypically heterogeneous, and that this lies beyond 243 
simple variation in carriage of the CTX-M encoding plasmids. 244 
In order to investigate if this phenotypic variation was mirrored in genotypic variation we 245 
genome sequenced ten ST131 strains isolated from unrelated clinical episodes in elderly 246 
patients living in a catchment area of approximately 5 million people. The strains were 247 
chosen to represent the wide spectrum in phenotypic and virulence gene carriage profiles 248 
observed in our population. In addition our data was compared to the recently announced 249 
NA114 genome, an ST131 strain isolated in India 20. The striking observation from our data 250 
is the lack of variation across the genomes of the ST131 strains isolated. Previous ExPEC 251 
genome studies have shown heterogeneity in genome architecture and content among strains, 252 
including between strains of the same sequence type as exemplified by UTI89, APEC01, and 253 
S88 which are all ST95, and ABU83972 with CFT073 which are both ST73 23, 28. In contrast 254 
all ten of our ST131 isolates show characteristics of being genetically monomorphic, with no 255 
variation in accessory genome content beyond carriage of antimicrobial resistance genes and 256 
associated plasmids. This would suggest the ST131 circulating in our population is not 257 
participating in accessory genome flux and that is a stable clone. Similarly there were no 258 
obvious discriminatory genomic signatures such as novel or unusual pathogenicity islands or 259 
virulence associated genes, although the absence of the sfa and pap fimbrial operons and 260 
deletion in the fimB gene from all isolates merits further study for biological relevance. 261 
Previous work by our group highlighted that both sfa and pap operons were statistically less 262 
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frequently found in ExPEC strains exhibiting an increased virulence phenotype 12. The 263 
absence of P fimbriae in our clinical ST131 sequenced isolates, and the insertion in fimB 264 
raises questions on the true virulent nature of our ST131 isolates. The relevance of these 265 
mutations and the true virulence of our ST131 strains is the focus of current work in our 266 
group. 267 
The genetically monomorphic nature of ST131 was further confirmed when phylogenetic 268 
analyses were performed based on whole genome data. SNP analysis of the ten ST131 269 
genome sequences showed low level polymorphism of 1324 SNPs between strains, (typically 270 
10-60 strain specific SNPs with one strain containing 386) in contrast to the 14, 413 SNPs 271 
between ST95 genome sequenced strains and the 9, 059 between ST73 genome sequenced 272 
strains. Indeed the levels of variation between our ST131 strains are similar to those observed 273 
in intra-strain variation during human bladder passage using ABU83972, where some 29 274 
SNPs occurred accompanied by one large deletion and four smaller deletions 29. Such low 275 
levels of variation are only seen in monomorphic, highly niche restricted and pathogenic 276 
subsets of species such as Salmonella Typhi and hypervirulent C. difficile O27 where inter-277 
strain SNP variation levels of 1,964 21 and 1,874 30 SNPs respectively have been reported. 278 
Both these organisms are subtypes of their respective species which have independently 279 
evolved into highly-pathogenic variants, and in the case of S. Typhi accompanied by gene 280 
loss and niche restriction. The inclusion of the Indian NA114 isolate in the middle of our 281 
phylogenetic tree raises the possibility that ST131 is a globally disseminated monophyletic 282 
clone which is evolving into subclades on the basis of antimicrobial resistance. 283 
Together the data from our study provides evidence of the circulation of a genetically 284 
monomorphic E. coli ST131 clone as a dominant strain isolated from unrelated clinical cases. 285 
To our knowledge this is the first time such a phenomenon has been reported for a sequence 286 
type of E. coli, where most studies focus on pathotypes encompassing diverse sequence types. 287 
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In order to determine the emergence of ST131 from a common environment to dominant 288 
human pathogen a full genome level investigation of a contemporaneous strain set separated 289 
geographically, temporally and by source reservoir is required, in conjunction with 290 
comparative studies of closely related strain types and more distant ExPEC relatives. This 291 
would allow detailed Bayesian analysis of clonal expansion of the ST131 with accurate 292 
dating, and provide clues as to the triggers for the evolution of pathogenic lineages of E. coli, 293 
particularly the role of antimicrobial resistance and ESBL carriage in driving evolutionary 294 
selection of ST131. Such informative clues will be of great value not just in understanding 295 
the emergence of ST131, but also how new dominant pathogenic variants of E. coli, such as 296 
the recent O104 epidemic, arise. 297 
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 402 
Table 1. Strains sequenced as part of this project 403 
Antibiotic resistance 
Strain ST Patient  
source AMP PIP/ TAZ RAD CTX CAZ MEM GEN AMC TMP CIP NIT 
CTX-M Invasion (cfu/ml)   VAG profile 
UTI18 131 Community R S R R R S R S R R R CTX-M-15 1.20E+03 PAI, fimH, fyuA, iutA, traT, kpsMT II, K5 
UTI188 131 Community R S S S S S S S R R S - 3.22E+03 papC, papG allele II, papG II, III, PAI, papA, fimH, traT,  
UTI226 131 Hospital S S S S S S S S S S S - 9.44E+03 PAI, fimH, ibeA, fyuA, traT, kpsMT II, K5 
UTI306 131 Community R R R R R S R R R S R CTX-M-15 7.22E+04 PAI, papA, fyuA, iutA, traT, kpsMT II, K5 
UTI32 131 Hospital R S R R R S S S R R S CTX-M-15 4.17E+04 papC, papG allele II, papG II, III, PAI, papA, fimH, afa/draBC, fyuA, iutA, traT 
UTI423 131 Community R S R S S S S S R R R - 1.01E+05 PAI, fimH, fyuA, iutA, traT, kpsMT II, K5 
UTI524 131 Community R S R R R S S S R R R CTX-M-15 7.20E+01 PAI, fimH, fyuA, iutA, traT, kpsMT II, K5 
UTI570 131 Community R S S S S S S S S R S - 7.83E+05 PAI, fimH, fyuA, iutA 
UTI587 131 Community R S R R R S R S R R S CTX-M-15 1.34E+05 PAI, fimH, fyuA, iutA, traT, kpsMT II, K5 
UTI62 131 Community R S R R R S S S R R R CTX-M-15 1.05E+02 PAI, fimH, fyuA, iutA, traT, kpsMT II, K5 
UTI48 12 Community R S S S S S S S R R R - 1.09E+03 PAI, fimH, fyuA, kpsMT II, K5 
The ST131 strains selected for sequencing represent the variation within the ST131 study population with regards to antibiotic resistance, CTX-M-15 possession, ability to 404 
invade epithelial cells and virulence associated gene (VAG) possession. Antibiotic abbreviations; AMP - Ampicillin (32 µg/ml), RAD – Cephradine (32 µg/ml), CTX – 405 
Cefotaxime (1 µg/ml), CAZ – Ceftazidime (1 µg/ml), PIP-TAZ – Piperacillin/Tazobactam (85 µg/ml), TMP – Trimethoprim (2 µg/ml), CIP – Ciprofloxacin (4 µg/ml), GEN 406 
– Gentamicin (2 µg/ml), AUG – Augmentin (32 µg/ml), NIT – Nitrofurantoin (32 µg/ml), MEM – Meropenem (2 µg/ml). VAG abbreviations; papC, papG, papA – regions 407 
within the pap operon which codes for P pili, afa/draBC – DR adhesins, PAI – CFT073 pathogenicity island marker, fimH – mannose specific adhesion subunit of type 1 408 
fimbriae, fyuA – yersiniabactin, iutA – aerobactin, traT – serum resistance, kpsMT II – group II capsule synthesis, K5 –K5 capsule synthesis. 409 
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Table 2. Publicly available reference genomes used in this study 410 
Strain ST Strain History Reference 
UTI89 95 Uncomplicated cystitis 19 
CFT073 73 Acute pyelonephritis 31 
ABU83972 73 Asymptomatic  bacteriuria 
29
 
Apec01 95 Poultry collibacilosis 32 
E. coli 536 92 Acute pyelonephritis 33 
E. coli HS 46 Human commensal 34 
IAI39 62 Urinary tract infection 
http://www.genoscope.cns.
fr/spip/-Escherichia-
fergusonii-coli-.html 
S88 95 Neonatal meningitis 
http://www.genoscope.cns.
fr/spip/-Escherichia-
fergusonii-coli-.html 
UMN026 597 Urinary tract infection 
http://www.genoscope.cns.
fr/spip/-Escherichia-
fergusonii-coli-.html 
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 411 
Figure legends: 412 
Figure 1. Minimum spanning trees of ExPEC isolated from our previous studies, with 413 
phenotypes (A – in vitro epithelial cell invasion; B – antimicrobial resistance) overlaid.  414 
 415 
Figure 2. BRIG alignment of E. coli ST131 UTI18 genome with publicly available ExPEC 416 
reference genomes. The location of the sfa and pap islands deletions are annotated, as is the 417 
location of the intact HPI. The comparisons are made relative to E. coli CFT073.  418 
 419 
Figure 3. BRIG alignment of the nine ST131 genomes sequenced using Illumina GAIIx. The 420 
comparisons are made relative to the Indian ST131 strain NA114, which is missing plasmid 421 
DNA fragments found in our ST131 isolates annotated on the circular diagram. 422 
 423 
Figure 4. Circular diagram showing the location of ST131 specific SNPs relative to the 424 
UTI18 genome. The innermost ring is GC content. The two outermost rings are CDS found 425 
on the coding and complementary strand. Red marks illustrate the position of ST131 SNPs. 426 
The SNP hotspot regions are annotated with arrows. The two regions completely free of 427 
SNPs are marked by rectangles outside of the circular diagram 428 
 429 
Figure 5. Phylogenetic tree of the ten ST131 isolates sequenced in this study relative to the 430 
outlier ST12 strain UTI48, and the reference strain used to assemble sequences and call SNPs, 431 
UTI89. The number of discriminatory SNPs are numerically presented. The Virulence 432 
associated gene carriage profile of the isolates is also presented by presence (red block) or 433 
absence (white block) of genes as determined by PCR in a previous study [17]. Strain 434 
characteristics are mapped on to the tree according to the key. 435 
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